Prevention and Treatment of Sarcopenia
Testa, Gianluca
Prevention and Treatment of Sarcopenia - Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 - 1 electronic resource (288 p.)
Open Access
Sarcopenia represents the decline in skeletal muscle mass and function with age, characterized by the muscle fiber's quality, strength, muscle endurance, and metabolic ability decreasing, as well as the fat and connective tissue growing.Reduction of muscle strength with aging leads to loss of functional capacity, causing disability, mortality, and other adverse health outcomes. Because of the increase of the proportion of elderly in the population, sarcopenia-related morbidity will become an increasing area of health care resource utilization.Diagnostic screening consists of individuation of body composition, assessed by DEXA, anthropometry, bioelectrical impedance, MRI, or CT scan. Management is possible with resistance training exercise and vibration therapy, nutritional supplements, and pharmacological treatment.The book includes articles from different nationalities, treating the experimental and medical applications of sarcopenia. The consequences of sarcopenia in frailty are treated in relation to other associated pathologies or lesions, as femoral neck fractures and hepatocellular carcinoma.
Creative Commons
English
books978-3-0365-1535-9 9783036515366 9783036515359
10.3390/books978-3-0365-1535-9 doi
Medicine
muscle-mass sleep efficiency sleep duration insomnia sarcopenia quality of life osteoporosis postmenopausal women sedentary behaviour aged exercise motivation hepatoma myokine decorin walking distance survival muscle strength resistance training randomized controlled trial nutritional status nutritional screening tools hospitalized older patients resistance exercise training muscle regulatory factors deconditioning skeletal muscle elderly hypertrophy multimorbidity polypathological patients frailty oxidative stress telomere length apoptosis spirometry urea fatigue respiratory system skeletal muscles lipids transaminases falls resistance exercise vibration electrical stimulation hip fracture diagnosis treatment prevention dual-energy X-ray absorptiometry bisphosphonate β-hydroxy-β-methylbutyrate exercise intervention fall risk balance anxiety depression sleep quality type 2 diabetes physical activity muscle mass protein intake accelerometer aerobic exercise training mitochondria endurance fractures ageing fractures complications recovery rehabilitation nutritional supplements physical therapy cognition brain-body cross-talk older persons prevalence physical functional performance epidemiologic studies aging panoramic ultrasound echogenicity specific force isokinetic dynamometry muscle quality strength older adults diagnostic criteria clinical
Prevention and Treatment of Sarcopenia - Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 - 1 electronic resource (288 p.)
Open Access
Sarcopenia represents the decline in skeletal muscle mass and function with age, characterized by the muscle fiber's quality, strength, muscle endurance, and metabolic ability decreasing, as well as the fat and connective tissue growing.Reduction of muscle strength with aging leads to loss of functional capacity, causing disability, mortality, and other adverse health outcomes. Because of the increase of the proportion of elderly in the population, sarcopenia-related morbidity will become an increasing area of health care resource utilization.Diagnostic screening consists of individuation of body composition, assessed by DEXA, anthropometry, bioelectrical impedance, MRI, or CT scan. Management is possible with resistance training exercise and vibration therapy, nutritional supplements, and pharmacological treatment.The book includes articles from different nationalities, treating the experimental and medical applications of sarcopenia. The consequences of sarcopenia in frailty are treated in relation to other associated pathologies or lesions, as femoral neck fractures and hepatocellular carcinoma.
Creative Commons
English
books978-3-0365-1535-9 9783036515366 9783036515359
10.3390/books978-3-0365-1535-9 doi
Medicine
muscle-mass sleep efficiency sleep duration insomnia sarcopenia quality of life osteoporosis postmenopausal women sedentary behaviour aged exercise motivation hepatoma myokine decorin walking distance survival muscle strength resistance training randomized controlled trial nutritional status nutritional screening tools hospitalized older patients resistance exercise training muscle regulatory factors deconditioning skeletal muscle elderly hypertrophy multimorbidity polypathological patients frailty oxidative stress telomere length apoptosis spirometry urea fatigue respiratory system skeletal muscles lipids transaminases falls resistance exercise vibration electrical stimulation hip fracture diagnosis treatment prevention dual-energy X-ray absorptiometry bisphosphonate β-hydroxy-β-methylbutyrate exercise intervention fall risk balance anxiety depression sleep quality type 2 diabetes physical activity muscle mass protein intake accelerometer aerobic exercise training mitochondria endurance fractures ageing fractures complications recovery rehabilitation nutritional supplements physical therapy cognition brain-body cross-talk older persons prevalence physical functional performance epidemiologic studies aging panoramic ultrasound echogenicity specific force isokinetic dynamometry muscle quality strength older adults diagnostic criteria clinical